Fig. 4: The molecular subtypes are associated with response to immune checkpoint inhibitors.
From: Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
Patients with advanced gastric cancer who were treated with immune checkpoint blockade were stratified by molecular subtypes. Response is defined by complete response (CR) or partial response (PR). Non-response is defined as stable disease (SD) or progressive disease (PD). The chi-square test was used to compare groups. Source data are provided as a source data file.
